Stock Market News

Edgewise Therapeutics stock falls after FDA deems data insufficient for accelerated approval

Jun 26, 2025 - 14:18
 0
Edgewise Therapeutics stock falls after FDA deems data insufficient for accelerated approval
Read More

Tags:

Previous Article

Lyft taps drivers for strategic input to help navigate robotaxi rollout

Next Article

FTSE 100 today: Index higher, pound above $1.37, Shell not buying BP

Related Posts

Judge dismisses Columbia University faculty lawsuit over Trump funding cuts, demands

Judge dismisses Columbia University faculty lawsuit ove...

Jun 16, 2025  0

Boeing awarded $227 million contract modification for l...

Jun 5, 2025  0

Evercore upgrades Block on lower lending risk and steady consumer trends

Evercore upgrades Block on lower lending risk and stead...

Jun 3, 2025  0